Mometasone furoate dry-powder inhaler for the control of persistent asthma.

about

Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma

P2860

Q24634033-9EC24424-7189-4AA5-AF27-08B306637225

P2860

Mometasone furoate dry-powder inhaler for the control of persistent asthma.

Item

http://www.wikidata.org/entity/Q36979360

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Mometasone furoate dry-powder inhaler for the control of persistent asthma.

@en

type

Item

label

Mometasone furoate dry-powder inhaler for the control of persistent asthma.

@en

prefLabel

Mometasone furoate dry-powder inhaler for the control of persistent asthma.

@en

P1476

Mometasone furoate dry-powder inhaler for the control of persistent asthma.

@en

P2093

Anthony D'Urzo

http://www.w3.org/2001/XMLSchema#string

P2860

Mometasone furoate is a less specific glucocorticoid than fluticasone propionate

Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy,

A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.

Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.

Bioavailability and metabolism of mometasone furoate: pharmacology versus methodology.

Indacaterol, a novel inhaled beta2-agonist, provides sustained 24-h bronchodilation in asthma.

Inhaled corticosteroids: past lessons and future issues.

Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma.

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.

P304

2871-2884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.8.16.2871

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17956206

http://www.w3.org/2001/XMLSchema#string

P921

asthma

Mometasone furoate dry-powder inhaler for the control of persistent asthma.

about

P2860

P2860

Mometasone furoate dry-powder inhaler for the control of persistent asthma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921